乳腺导管内原位癌

  • 网络ductal carcinoma in situ DCIS
乳腺导管内原位癌乳腺导管内原位癌
  1. 在乳腺导管内原位癌中表达阳性率为55.0%(11/20),浸润性乳腺癌中为85.0%(51/60);HIF-1α表达与淋巴结转移及雌激素受体状态有关(P0.01)。

    However , the positive expression rate of HIF-1 α in the ductal carcinoma in situ ( DCIS ) was 55.0 % ( 11 / 20 ) and the infiltrative breast cancer was 85.0 % ( 51 / 60 ) .

  2. 超声造影诊断乳腺导管内原位癌1例

    Contrast-enhanced ultrasonography of brest ductal carcinoma in situ : case report

  3. 乳腺导管内原位癌和内癌微小浸润的声像图表现及其病理基础

    Sonographic Features of Breast Ductal Carcinoma in Situ and Intraductal Carcinoma with Microinvasion : Correlated to Histopathology